rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Cipla Ltd.

500087 CIPLA Group (A)

22 Jul,15:29
1490.00
4.85 (0.33%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Cipla Ltd.

BUYSELL
68,963 1,485.15 1,506.75 - 1,470.05 1,581.70 - 1,028.00 120,332.41
NSE | BSE

Cipla Ltd.

CIPLA

22 Jul,15:55
1490.00
4.50 (0.30%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Refresh
Zoom
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Cipla Ltd.

BUYSELL
1,328,847 1485.50 1,507.05 - 1,470.65 1,582.00 - 1,027.00 1,984,566,552.15

News for Cipla Ltd.

Cipla Faces Rs...
Cipla Faces Rs 773 Crore I-T Demand: Details - Business News
Cipla receives a Rs 773.44 crore demand notice from the income tax department for assessment years 2015-16 to 2022-23. The company plans to appeal the order.
Jul 16, 2024 16:40
Pharma Budget...
Pharma Budget Wish List: Tax Benefits, IP Rights
Pharma industry bodies call for tax incentives, stronger IP regime and R&D support in the upcoming Union Budget to boost domestic growth.
Jul 07, 2024 11:15
Orchid Pharma &...
Orchid Pharma & Cipla Partner for New Antibiotic in India
Orchid Pharma and Cipla collaborate to distribute Cefepime-Enmetazobactam, a new antibiotic for complicated infections, across India. The partnership aims to combat antimicrobial resistance and...
Jun 28, 2024 19:42
Cipla Gets USFDA...
Cipla Gets USFDA Nod for Generic Lanreotide Injection
Cipla receives USFDA approval to market generic Lanreotide injection, a treatment for acromegaly and other conditions. The drug is a therapeutic equivalent to Somatuline Depot Injection.
May 22, 2024 12:13
Cipla Promoters...
Cipla Promoters Sell 2.53% Stake for Rs 2,750 Cr | News
Cipla promoters offload 2.53% stake for Rs 2,750 crore to create liquidity for philanthropy and other needs. The deal was completed through a block deal on the NSE, with buyers including Aditya...
May 15, 2024 19:25

More News for Cipla Ltd. »

(Rs. Crore)

Financial Results of Cipla Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales16,574.3415,790.6013,091.7913,900.5812,659.15
Operating profit4,484.153,792.583,366.473,721.562,707.29
Interest20.2527.0226.9345.0736.05
Gross profit5,534.564,222.354,006.243,906.773,564.09
EPS (Rs)50.5031.1436.6630.6128.75

See more in Research Center »

Statements:Balance Sheet  |  P&L  |  Cash Flow
More:Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

About Cipla Ltd.

Cipla Limited (stylized as Cipla) is an Indian multinational pharmaceutical company headquartered in Mumbai. Cipla primarily focuses on developing medication to treat respiratory disease, cardiovascular disease, arthritis, diabetes, depression, and various other medical conditions. Cipla has 47 manufacturing locations across the world and sells its products in 86 countries. It is the third-largest drug producer in India. Wikipedia

News for Pharmaceuticals and health care

Sebi Extends...
Sebi Extends Deadline for Ease of Doing Business Comments
Sebi extends deadline for public comments on proposals aimed at simplifying business processes and reducing compliance burden for listed firms.
Jul 22, 2024 18:55
MEHAIR Orders 50...
MEHAIR Orders 50 Amphibious Aircraft for Seaplane Operations
MEHAIR, a domestic seaplane operator, has placed an order for up to 50 amphibious aircraft from Mallard Enterprises, aiming to re-launch operations in December 2024.
Jul 22, 2024 18:52
Indian Overseas...
Indian Overseas Bank Q1 Profit Up 26.6% to Rs 633 cr
Indian Overseas Bank reported a 26.60% rise in net profit for Q1 FY25, reaching Rs 633 crore. Total income grew by 21.54%, driven by increased interest and non-interest income. The bank also saw...
Jul 22, 2024 18:47
CapitaLand India...
CapitaLand India Trust Acquires Rs 676 Cr Office Building in Navi Mumbai
CapitaLand India Trust (CLINT) has completed the acquisition of a 0.82 million sq ft office building in Navi Mumbai for Rs 676 crore. The building is fully leased to reputed Indian and...
Jul 22, 2024 18:34
Retail Investors'...
Retail Investors' Derivatives Trading Driven by 'Gambling Instincts': Eco Survey
Economic Survey 2023-24 highlights the rise of retail investor participation in derivatives trading, linking it to 'gambling instincts' and warning of potential risks. The survey emphasizes the...
Jul 22, 2024 18:30

More News »

Top News

Sebi Extends...
Sebi Extends Deadline for Ease of Doing Business Comments
Sebi extends deadline for public comments on proposals aimed at simplifying business processes and reducing compliance burden for listed firms.
Jul 22, 2024 18:55
MEHAIR Orders 50...
MEHAIR Orders 50 Amphibious Aircraft for Seaplane Operations
MEHAIR, a domestic seaplane operator, has placed an order for up to 50 amphibious aircraft from Mallard Enterprises, aiming to re-launch operations in December 2024.
Jul 22, 2024 18:52
Indian Overseas...
Indian Overseas Bank Q1 Profit Up 26.6% to Rs 633 cr
Indian Overseas Bank reported a 26.60% rise in net profit for Q1 FY25, reaching Rs 633 crore. Total income grew by 21.54%, driven by increased interest and non-interest income. The bank also saw...
Jul 22, 2024 18:47
India's Economic Survey: Govts Should Renounce Powers
India's Economic Survey 2023-24 suggests governments should relinquish some powers to improve governance, promote economic growth, and enhance public well-being.
Jul 22, 2024 18:46
CapitaLand India...
CapitaLand India Trust Acquires Rs 676 Cr Office Building in Navi Mumbai
CapitaLand India Trust (CLINT) has completed the acquisition of a 0.82 million sq ft office building in Navi Mumbai for Rs 676 crore. The building is fully leased to reputed Indian and...
Jul 22, 2024 18:34

More Top News »

Report Card

PE Ratios
29.38
EPS (Rs.)
50.50
Sales (Rs. Cr)
4,036.66
Face Value (Rs.)
2
Net Profit Margin (%)
15.91
Last Bonus
3:2
Last Dividend(%)
650
Return on Average Equity
10.21

BSE Announcements from Cipla Ltd. (See all)

announcement Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation - 3 day(s) ago
announcement Announcement under Regulation 30 (LODR)-Newspaper Publication - 4 day(s) ago

Compare 'Cipla Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,593.65
  • Compare
  • Divi's Laboratories Ltd.
  • 4,582.30
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,185.30
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,665.10
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,053.90
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,517.15
  • Compare
  • Max Healthcare Institute Ltd.
  • 933.40
  • Compare
  • Alkem Laboratories Ltd.
  • 5,265.25
  • Compare

Mutual Funds Invested

Most Active

  • Change (Rs.)
  •  

REDIFFGURUS

Hello Sir I am an NRI and I still have an old SB...

Hello Col.I am 34 years old, monthly salary is 1...

I am 66, my annual income is 8 lacs. What are the...

Im a 55-year-old man working in a nationalized bank....

Hi, I want to understand about SWP mutual fund...

I have left my job 1.5 year back for pursuing...

More REDIFFGURUS

RediffGurus

Money question

Can you please advise SIP in mutual fund. i can take...

Cipla Ltd. performance snapshot

If you had invested Rs.  in Cipla Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio
Cipla Ltd.
Share Price » Fundamentals » Financial » Technicals » Option Chain » Trade Now »

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume

ALL MONEYWIZ PAGES

rediff on the net© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
Close
Add Cipla Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Cipla Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close